HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics

AIDS

Volumn 29, Issue 15, 2015, Pages 2025-2033

  Kinuthia, John ^a   Drake, Alison L ^b   Matemo, Daniel ^a   Richardson, Barbra A ^c   Zeh, Clement ^d   Osborn, Lusi ^a   Overbaugh, Julie ^e   Scott McClelland, R ^b   John Stewart, Grace ^b,f  

^a KENYATTA NATIONAL HOSPITAL   (Kenya)

^b Department of Global Health ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e USA   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

acute; HIV; incidence; mother to child transmission; seroconversion

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA; COHORT ANALYSIS; CONCURRENT SEXUAL PARTNERSHIP; CONDOM; DIARRHEA; FEMALE; FEVER; FOLLOW UP; GENITAL TRACT INFECTION; GONORRHEA; HEADACHE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION; KENYA; MAJOR CLINICAL STUDY; MALAISE; NUCLEIC ACID AMPLIFICATION; PAPULAR RASH; PATIENT COUNSELING; PRE-EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; SORE THROAT; SYPHILIS; TRICHOMONAS VAGINALIS; VAGINITIS; VOMITING; CHLAMYDIASIS; COMPLICATION; HIV INFECTIONS; LONGITUDINAL STUDY; MYCOSIS; PREGNANCY COMPLICATION; SEXUAL BEHAVIOR; TRANSMISSION; TRICHOMONIASIS; VERTICAL TRANSMISSION; YOUNG ADULT;

ADULT; CHLAMYDIA INFECTIONS; FEMALE; GONORRHEA; HIV INFECTIONS; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KENYA; LONGITUDINAL STUDIES; MYCOSES; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; REPRODUCTIVE TRACT INFECTIONS; SEXUAL BEHAVIOR; TRICHOMONAS INFECTIONS; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84965010213     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000793     Document Type: Article

References (47)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva: UNAIDS; 2013.
2. World Health Organization. Consolidated guidelines on the use of antriretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013. http://www.who.int/hiv/pub/guidelines/arv2013/en/[Accessed 18 May 2015].
3. UNAIDS. The gap report. Geneva: UNAIDS; 2014.
4. Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med 2014; 11:e1001608.
5. Gray R, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005; 366:1182-1188.
6. Kinuthia J, Kiarie JN, Farquhar CF, Richardson B, Nduati R, Mbori-Ngacha D, et al. Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res 2010; 8:510-514.
7. Moodley D, Esterhuizen TM, Pather T, Chetty V, Ngaleka L. High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS 2009; 23:1255-1259.
8. De Schacht C, Hoffman HJ, Mabunda N, Lucas C, Alons CL, Madonela A, et al. High rates of HIV seroconversion in pregnant women and low reported levels of HIV testing among male partners in southern Mozambique: results from a mixed methods study. PLoS One 2014; 9:e115014.
9. Wira CR, Fahey JV, Rodriguez-Garcia M, Shen Z, Patel MV. Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens. Am J Reprod Immunol 2014; 72:236-258.
10. Sheffield JS, Wendel GD, McIntire DD, Norgard MV. The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci 2009; 16:20-31.
11. Rodriguez-Garcia M, Patel MV, Wira CR. Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol 2013; 97:74-84.
12. Onah HE, Iloabachie GC, Obi SN, Ezugwu FO, Eze JN. Nigerian male sexual activity during pregnancy. Int J Gynaecol Obstet 2002; 76:219-223.
13. Lawoyin TO, Larsen U. Male sexual behaviour during wife's pregnancy and postpartum abstinence period in Oyo state, Nigeria. J Biosoc Sci 2002; 34:51-63.
14. National AIDS and STI Control Programme, Ministry of Health, Kenya. Kenya AIDS indicator survey 2012: preliminary report. Nairobi, Kenya: Ministry of Health; 2013.
15. National Guidelines for reproductive tract infection services. 1st ed. Republic of Kenya, Ministry of Health; 2006.
16. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-1879.
17. Stekler J, Maenza J, Stevens CE, Swenson PD, Coombs RW, Wood RW, et al. Screening for acute HIV infection: lessons learned. Clin Infect Dis 2007; 44:459-461.
18. McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, et al. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS (19 Suppl 2):2005:S25-S30.
19. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005; 352:1873-1883.
20. Lee KJ, Carlin JB. Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation. Am J Epidemiol 2010; 171:624-632.
21. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399-410.
22. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Nquqi EN, Keli F, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004; 291:2555-2562.
23. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-129.
24. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
25. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Nonulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95-102.
26. Kenya National Bureau of Statistics (KNBS), ICF Macro. Kenya demographic and health survey 2008-2009. Calverton, MD: KNBS, ICF Macro; 2010.
27. Vuylsteke B. Current status of syndromic management of sexually transmitted infections in developing countries. Sex Transm Infect 2004; 80:333-334.
28. Mayaud P, Grosskurth H, Changalucha J, Todd J, West B, Gabone R, et al. Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics. Bull World Health Organ 1995; 73:621-630.
29. Kelly RJ, Gray RH, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, et al. Age differences in sexual partners and risk of HIV-1 infection in rural Uganda. J Acquir Immune Defic Syndr 2003; 32:446-451.
30. Glynn JR, Caraël M, Auvert B, Kahindo M, Chege J, Musonda R, et al. Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS 2001; 15:S51-S60.
31. Gregson S, Nyamukapa CA, Garnett GP, Mason PR, Zhuwau T, Caraël M, et al. Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet 2002; 359:1896-1903.
32. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
33. Msuya SE, Mbizvo EM, Hussain A, Uriyo J, Sam NE, Stray-Pedersen B. Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs. AIDS Care 2008; 20:700-709.
34. Farquhar C, Kiarie JN, Richardson BA, Kabura MN, John FN, Nduati RW, et al. Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr 2004; 37:1620-1626.
35. Osoti AO, John-Stewart G, Kiarie J, Richardson B, Kinuthia J, Krakowiak D, et al. Home visits during pregnancy enhance male partner HIV counselling and testing in Kenya: a randomized clinical trial. AIDS 2014; 28:95-103.
36. UNAIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva: UNAIDS; 2011.
37. National AIDS and STI Control Programme. Guidelines for prevention of mother to child 6 transmission (PMTCT) of HIV/AIDS in Kenya. Nairobi: Ministry of Health; 2012.
38. Sansom SL, Jamieson DJ, Farnham PG, Bulterys M, Fowler MG. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission. Obstet Gynecol 2003; 102:782-790.
39. Williams B, Costello M, McHugh E, Le Prevost M, Phil-Ebosie A, Tilsed C, et al. Repeat antenatal HIV testing in the third trimester: a study of feasibility and maternal uptake rates. HIV Med 2014; 15:362-366.
40. Criniti SM, Aaron E, Levine AB. Using the rapid HIV test to rescreen women in the third trimester of pregnancy. J Midwifery Women's Health 2009; 54:492-496.
41. Chu C1 PAS. Diagnosis and initial management of acute HIV infection. Am Fam Phys 2010; 81:1239-1244.
42. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002; 16:1119-1129.
43. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997; 102:117-124.
44. Morandi P-A, Schockmel GA, Yerly S, Burgisser P, Erb P, Matter L, et al. Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J Clin Microbiol 1998; 36:1534-1538.
45. Quinn TC, Brookmeyer R, Kline R, Shepherd M, Paranjape R, Mehendale S, et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000; 14:2751-2757.
46. Pilcher CD, McPherson J, Leone PA, Smurzynski M, Owen-O'Dowd J, Peace-Brewer AL, et al. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA 2002; 288:216-221.
47. Baeten JM, Richardson BA, Martin HL Jr, Nyange PM, Lavreys L, Ngugi EN, et al. Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials. J Acquir Immune Defic Syndr 2000; 24:458-464.